mp0250
Botanicalexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02194426)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatocyte growth factor activatorINHIBITOR
HGFAC inhibitor
- Vascular endothelial growth factor CINHIBITOR
VEGFC inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mp0250
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03418532 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2018 | Molecular Partners AG |
| NCT03136653 | Phase 1/Phase 2 (Phase 2) | May 23, 2017 | Molecular Partners AG |
| NCT02194426 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2014 | Molecular Partners AG |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Molecular Partners AG | For profit | 3 | 3 | 1 | 2014 |
1 organizations
Page 1 / 1